Capstone Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,043	Closed	-$193K	–	1462
2024 Q4	$193K	Sell	1,043 -116	-10%	-$22.3K	﹤0.01%	1601
2024 Q3	$228K	Sell	1,159 -368	-24%	-$76.5K	﹤0.01%	1530
2024 Q2	$315K	Buy	1,527 +789	+107%	+$179K	0.01%	1568
2024 Q1	$200K	Buy	738 +74	+11%	+$17.7K	﹤0.01%	2014
2023 Q4	$157K	Buy	+664	New	+$131K	﹤0.01%	1846
2023 Q3	–	Sell	-198	Closed	-$41.6K	–	2133
2023 Q2	$41.6K	Buy	198 +20	+11%	+$3.98K	﹤0.01%	1781
2023 Q1	$35.9K	Buy	+178	New	+$40.3K	﹤0.01%	1444
2022 Q2	–	Sell	-721	Closed	-$205K	–	1905
2022 Q1	$205K	Buy	+721	New	+$222K	﹤0.01%	1719
2021 Q4	–	Sell	-413	Closed	-$160K	–	1903
2021 Q3	$170K	Buy	+413	New	+$172K	﹤0.01%	1718
2021 Q2	–	Hold	0	–	–	–	1794
2017 Q2	–	Sell	-29,088	Closed	-$2.62M	–	681
2017 Q1	$2.62M	Buy	+29,088	New	+$2.47M	0.13%	232
2016 Q4	–	Sell	-11,852	Closed	-$987K	–	958
2016 Q3	$987K	Buy	11,852 +1,602	+16%	+$134K	0.05%	384
2016 Q2	$845K	Sell	10,250 -7,400	-42%	-$610K	0.04%	385
2016 Q1	$1.34M	Buy	+17,650	New	+$1.31M	0.07%	254